{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:36:38Z","timestamp":1766136998263},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.clindermatol.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T06:21:49Z","timestamp":1523341309000},"page":"442-449","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 years"],"prefix":"10.1016","volume":"36","author":[{"given":"Jeffrey P.","family":"Callen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2018.04.002_bb0005","series-title":"Dermatological Signs of Systemic Disease","first-page":"1","article-title":"Lupus erythematosus","author":"Hansen","year":"2017"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0010","series-title":"Dermatology","first-page":"662","article-title":"Lupus erythematosus","author":"Lee","year":"2018"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48-49","author":"Kuhn","year":"2014","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.clindermatol.2018.04.002_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.det.2016.02.006","article-title":"Practice and educational gaps in lupus, dermatomyositis, and morphea","volume":"34","author":"Fett","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0025","first-page":"297","article-title":"Lupus Erythemateux","volume":"3","author":"Cazenave","year":"1851","journal-title":"Ann Maladie Peau Syph"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.1886.04250010121001","article-title":"Lupus erythematosus","volume":"6","author":"Reynolds","year":"1886","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0035","first-page":"419","article-title":"The L.E. cell phenomenon","volume":"27","author":"Hargraves","year":"1952","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0040","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.1780200803","article-title":"Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease","volume":"20","author":"Provost","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.clindermatol.2018.04.002_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI108007","article-title":"Antibodies to cellular antigens in Sj\u00f6gren\u2019s syndrome","volume":"55","author":"Alspaugh","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0050","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1172\/JCI107691","article-title":"Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease","volume":"53","author":"Gilliam","year":"1974","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clindermatol.2018.04.002_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.1970.04000070044007","article-title":"Immunofluorescent \u201cband\u201d test for lupus erythematosus. II. Employing skin lesions","volume":"102","author":"Burnham","year":"1970","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.clindermatol.2018.04.002_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005792-197603000-00006","article-title":"Chronic cutaneous lupus erythematosus (DLE)\u2014a clinical and laboratory investigation of 80 patients","volume":"55","author":"Prystowsky","year":"1976","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.clindermatol.2018.04.002_bb0065","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.clindermatol.2018.04.002_bb0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.clindermatol.2018.04.002_bb0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2018.04.002_bb0080","doi-asserted-by":"crossref","first-page":"e000085","DOI":"10.1136\/lupus-2015-000085","article-title":"Redefining cutaneous lupus erythematosus: A proposed international consensus approach and results of a preliminary questionnaire","volume":"2","author":"Merola","year":"2015","journal-title":"Lupus Sci Med"},{"issue":"2","key":"10.1016\/j.clindermatol.2018.04.002_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2017.02.030","article-title":"Development of classification criteria for discoid lupus erythematosus: Results of a delphi exercise","volume":"77","author":"Elman","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0190-9622(90)70020-I","article-title":"Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation","volume":"22","author":"Lehmann","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2018.04.002_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clindermatol.2018.04.002_bb0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/ejd.2016.2912","article-title":"Drug-induced cutaneous lupus erythematosus: 88 new cases","volume":"27","author":"Laurinaviciene","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.clindermatol.2018.04.002_bb0105","doi-asserted-by":"crossref","DOI":"10.5070\/D3233034281","article-title":"An update in drug-induced subacute cutaneous lupus erythematosus","volume":"23","author":"Michaelis","year":"2017","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.clindermatol.2018.04.002_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.clindermatol.2018.04.002_bb0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: A population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.clindermatol.2018.04.002_bb0120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.mayocp.2016.10.030","article-title":"Subacute cutaneous lupus erythematosus: Clinical characteristics, disease associations, treatments, and outcomes in a series of 90 patients at Mayo Clinic, 1996-2011","volume":"92","author":"Alniemi","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0125","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archderm.1954.01540240088009","article-title":"Possible discoid lupus erythematosus in newborn infant; report of a case with subsequent development of acute systemic lupus erythematosus in mother","volume":"70","author":"McCuistion","year":"1954","journal-title":"AMA Arch Derm Syphilol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/archderm.1976.01630290046010","article-title":"Neonatal lupus erythematosus. Report of four cases with review of the literature","volume":"112","author":"Vonderheid","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(81)70011-2","article-title":"Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome","volume":"4","author":"Franco","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.1780260215","article-title":"Neonatal lupus erythematosus with heart block: Family study of a patient with anti-SS-A and SS-B antibodies","volume":"26","author":"Lockshin","year":"1983","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.clindermatol.2018.04.002_bb0145","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/rheumatology\/kex191","article-title":"Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: A single-centre cohort study","volume":"56","author":"Barsalou","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archderm.1982.01650180046015","article-title":"Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic and prognostic examination of 62 patients","volume":"118","author":"Callen","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780310811","article-title":"Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients","volume":"3","author":"Callen","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.clindermatol.2018.04.002_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","article-title":"Incidence of cutaneous lupus erythematosus, 1965-2005: A population-based study","volume":"145","author":"Durosaro","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0165","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: A population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gr\u00f6nhagen","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.clindermatol.2018.04.002_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","article-title":"Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus","volume":"150","author":"Wieczorek","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"16","key":"10.1016\/j.clindermatol.2018.04.002_bb0175","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clindermatol.2018.04.002_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.clindermatol.2018.04.002_bb0185","first-page":"1716","article-title":"Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus","volume":"25","author":"Rahman","year":"1998","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.clindermatol.2018.04.002_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"American Academy of Ophthalmology: Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.clindermatol.2018.04.002_bb0195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","article-title":"Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: A French multicenter prospective study","volume":"148","author":"Franc\u00e8s","year":"2012","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.clindermatol.2018.04.002_bb0200","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3899\/jrheum.150379","article-title":"Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence","volume":"42","author":"Durcan","year":"2015","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.clindermatol.2018.04.002_bb0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaad.2015.09.064","article-title":"The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study","volume":"74","author":"Chasset","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archderm.139.1.50","article-title":"Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus","volume":"139","author":"Housman","year":"2003","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.clindermatol.2018.04.002_bb0215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.clindermatol.2018.04.002_bb0220","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/art.40052","article-title":"Brief report: Pharmacodynamics, safety, and clinical efficacy of AMG 811, a human anti-interferon-\u03b3 antibody, in patients with discoid lupus erythematosus","volume":"69","author":"Werth","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.002_bb0225","first-page":"CD002954","article-title":"Drugs for discoid lupus erythematosus","volume":"5","author":"Jessop","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:37:10Z","timestamp":1693615030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X18300610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0738081X18300610"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.002","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 years","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}